nach oben

Seminars in Immunopathology

Erschienen in:

01.09.2009 | Review

Biliary atresia

verfasst von: Giorgina Mieli-Vergani, Diego Vergani

Erschienen in: Seminars in Immunopathology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Biliary atresia (BA) is a condition unique to infancy. It results from inflammatory destruction of the intrahepatic and extrahepatic bile ducts. It is the most frequent surgically correctable liver disorder in infancy and the most frequent indication for liver transplantation in paediatric age. Clinical presentation is in the first few weeks of life with conjugated hyperbilirubinaemia (dark urine and pale stools); other manifestations of liver disease, such as failure to thrive, splenomegaly and ascites, appear only later, when surgery is unlikely to be successful. Hence, all infants with conjugated hyperbilirubinaemia must be urgently referred to specialised centres for appropriate treatment. Success of surgery depends on the age at which it is performed. With corrective surgery, followed, when necessary, by liver transplantation, the overall survival rate is approximately 90%. The cause of BA is unknown, but there is evidence for the involvement of infectious, genetic and immunologic mechanisms, which will be discussed in this review.

Houwen RH, Kerremans II, van Steensel-Moll HA, van Romunde LK, Bijleveld CM, Schweizer P (1988) Time–space distribution of extrahepatic biliary atresia in The Netherlands and West Germany. Z Kinderchir 43(2):68–71PubMed

Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B (1999) Epidemiology of biliary atresia in France: a national study 1986–96. J Hepatol 31(6):1006–1013PubMedCrossRef

McKiernan PJ, Baker AJ, Kelly DA (2000) The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 355(9197):25–29PubMedCrossRef

Strickland AD, Shannon K (1982) Studies in the etiology of extrahepatic biliary atresia: time–space clustering. J Pediatr 100(5):749–753PubMedCrossRef

Danks DM, Campbell PE, Jack I, Rogers J, Smith AL (1977) Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child 52(5):360–367PubMedCrossRef

Yoon PW, Bresee JS, Olney RS, James LM, Khoury MJ (1997) Epidemiology of biliary atresia: a population-based study. Pediatrics 99(3):376–382PubMedCrossRef

Shim WK, Kasai M, Spence MA (1974) Racial influence on the incidence of biliary atresia. Prog Pediatr Surg 6:53–62PubMed

Vic P, Gestas P, Mallet EC, Arnaud JP (1994) [Biliary atresia in French Polynesia. Retrospective study of 10 years]. Arch Pediatr 1(7):646–651PubMed

Ayas MF, Hillemeier AC, Olson AD (1996) Lack of evidence for seasonal variation in extrahepatic biliary atresia during infancy. J Clin Gastroenterol 22(4):292–294PubMedCrossRef

10.

Davenport M, Dhawan A (1998) Epidemiologic study of infants with biliary atresia. Pediatrics 101(4 Pt 1):729–730PubMedCrossRef

11.

Gautier M, Eliot N (1981) Extrahepatic biliary atresia. Morphological study of 98 biliary remnants. Arch Pathol Lab Med 105(8):397–402PubMed

12.

Desmet VJ (1992) Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation”. Hepatology 16(4):1069–1083PubMedCrossRef

13.

Mieli-Vergani G, Howard ER, Portman B, Mowat AP (1989) Late referral for biliary atresia—missed opportunities for effective surgery. Lancet 1(8635):421–423PubMedCrossRef

14.

Chen SM, Chang MH, Du JC et al (2006) Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 117(4):1147–1154PubMedCrossRef

15.

Farrant P, Meire HB, Mieli-Vergani G (2000) Ultrasound features of the gall bladder in infants presenting with conjugated hyperbilirubinaemia. Br J Radiol 73(875):1154–1158PubMed

16.

Park WH, Choi SO, Lee HJ, Kim SP, Zeon SK, Lee SL (1997) A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Pediatr Surg 32(11):1555–1559PubMedCrossRef

17.

Lai MW, Chang MH, Hsu SC et al (1994) Differential diagnosis of extrahepatic biliary atresia from neonatal hepatitis: a prospective study. J Pediatr Gastroenterol Nutr 18(2):121–127PubMed

18.

Guibaud L, Lachaud A, Touraine R et al (1998) MR cholangiography in neonates and infants: feasibility and preliminary applications. AJR Am J Roentgenol 170(1):27–31PubMed

19.

Norton KI, Glass RB, Kogan D, Lee JS, Emre S, Shneider BL (2002) MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology 222(3):687–692PubMedCrossRef

20.

Wilkinson ML, Mieli-Vergani G, Ball C, Portmann B, Mowat AP (1991) Endoscopic retrograde cholangiopancreatography in infantile cholestasis. Arch Dis Child 66(1):121–123PubMedCrossRef

21.

Iinuma Y, Narisawa R, Iwafuchi M et al (2000) The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis. J Pediatr Surg 35(4):545–549PubMedCrossRef

22.

Markowitz J, Daum F, Kahn EI et al (1983) Arteriohepatic dysplasia. I. Pitfalls in diagnosis and management. Hepatology 3(1):74–76PubMed

23.

Kasai M, Suzuki S (1959) A new operation for “non-correctable” biliary atresia: Hepatic porto-enterostomy. Shujutsu 13:733–739

24.

Ohi R (2001) Surgery for biliary atresia. Liver 21(3):175–182PubMedCrossRef

25.

McClement JW, Howard ER, Mowat AP (1985) Results of surgical treatment for extrahepatic biliary atresia in United Kingdom 1980–2. Survey conducted on behalf of the British Paediatric Association Gastroenterology Group and the British Association of Paediatric Surgeons. Br Med J (Clin Res Ed) 290(6465):345–347CrossRef

26.

Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER (1997) Biliary atresia: the King’s College Hospital experience (1974–1995). J Pediatr Surg 32(3):479–485PubMedCrossRef

27.

Ohi R (2000) Biliary atresia. A surgical perspective. Clin Liver Dis 4(4):779–804PubMedCrossRef

28.

Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K (2003) Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg 38(7):997–1000PubMedCrossRef

29.

Esteves E, Clemente Neto E, Ottaiano Neto M, Devanir J Jr, Esteves Pereira R (2002) Laparoscopic Kasai portoenterostomy for biliary atresia. Pediatr Surg Int 18(8):737–740PubMed

30.

Aspelund G, Ling SC, Ng V, Kim PC (2007) A role for laparoscopic approach in the treatment of biliary atresia and choledochal cysts. J Pediatr Surg 42(5):869–872PubMedCrossRef

31.

Dutta S, Woo R, Albanese CT (2007) Minimal access portoenterostomy: advantages and disadvantages of standard laparoscopic and robotic techniques. J Laparoendosc Adv Surg Tech A 17(2):258–264PubMedCrossRef

32.

Meehan JJ, Elliott S, Sandler A (2007) The robotic approach to complex hepatobiliary anomalies in children: preliminary report. J Pediatr Surg 42(12):2110–2114PubMedCrossRef

33.

Davenport M, De Ville de Goyet J, Stringer MD et al (2004) Seamless management of biliary atresia in England and Wales (1999–2002). Lancet 363(9418):1354–1357PubMedCrossRef

34.

Serinet MO, Broue P, Jacquemin E et al (2006) Management of patients with biliary atresia in France: results of a decentralized policy 1986–2002. Hepatology 44(1):75–84PubMedCrossRef

35.

Ohi R, Nio M, Chiba T, Endo N, Goto M, Ibrahim M (1990) Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg 25(4):442–445PubMedCrossRef

36.

Chiba T, Ohi R, Nio M, Ibrahim M (1992) Late complications in long-term survivors of biliary atresia. Eur J Pediatr Surg 2(1):22–25PubMedCrossRef

37.

Davenport M (2005) Biliary atresia. Semin Pediatr Surg 14(1):42–48PubMedCrossRef

38.

Hadzic N, Davenport M, Tizzard S, Singer J, Howard ER, Mieli-Vergani G (2003) Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable? J Pediatr Gastroenterol Nutr 37(4):430–433PubMedCrossRef

39.

Karrer FM, Lilly JR (1985) Corticosteroid therapy in biliary atresia. J Pediatr Surg 20(6):693–695PubMedCrossRef

40.

Alvaro D, Gigliozzi A, Marucci L et al (2002) Corticosteroids modulate the secretory processes of the rat intrahepatic biliary epithelium. Gastroenterology 122(4):1058–1069PubMedCrossRef

41.

Miner PB Jr, Gaito JM (1979) Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard. Biochem Pharmacol 28(7):1063–1066PubMedCrossRef

42.

Hsieh CS, Huang CC, Huang LT, Tsai YJ, Chou MH, Chuang JH (2004) Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats. J Pediatr Surg 39(1):10–15PubMedCrossRef

43.

Vejchapipat P, Passakonnirin R, Sookpotarom P, Chittmittrapap S, Poovorawan Y (2007) High-dose steroids do not improve early outcome in biliary atresia. J Pediatr Surg 42(12):2102–2105PubMedCrossRef

44.

Escobar MA, Jay CL, Brooks RM et al (2006) Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 41(1):99–103PubMedCrossRef

45.

Stringer MD, Davison SM, Rajwal SR, McClean P (2007) Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg 42(8):1324–1328PubMedCrossRef

46.

Shimadera S, Iwai N, Deguchi E, Kimura O, Fumino S, Ono S (2007) The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia. Eur J Pediatr Surg 17(2):100–103PubMedCrossRef

47.

Petersen C, Harder D, Melter M et al (2008) Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 103(3):712–719PubMedCrossRef

48.

Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N (2007) Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 46(6):1821–1827PubMedCrossRef

49.

Ohkohchi N, Chiba T, Ohi R, Mori S (1989) Long-term follow-up study of patients with cholangitis after successful Kasai operation in biliary atresia: selection of recipients for liver transplantation. J Pediatr Gastroenterol Nutr 9(4):416–420PubMed

50.

Sokol RJ, Mack C (2001) Etiopathogenesis of biliary atresia. Semin Liver Dis 21(4):517–524PubMedCrossRef

51.

Schweizer P, Kerremans J (1988) Discordant findings in extrahepatic bile duct atresia in 6 sets of twins. Z Kinderchir 43(2):72–75PubMed

52.

Hyams JS, Glaser JH, Leichtner AM, Morecki R (1985) Discordance for biliary atresia in 2 sets of monozygotic twins. J Pediatr 107(3):420–422PubMedCrossRef

53.

Davenport M, Savage M, Mowat AP, Howard ER (1993) Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery 113(6):662–668PubMed

54.

Mazziotti MV, Willis LK, Heuckeroth RO et al (1999) Anomalous development of the hepatobiliary system in the Inv mouse. Hepatology 30(2):372–378PubMedCrossRef

55.

Yokoyama T, Copeland NG, Jenkins NA, Montgomery CA, Elder FF, Overbeek PA (1993) Reversal of left–right asymmetry: a situs inversus mutation. Science 260(5108):679–682PubMedCrossRef

56.

Schon P, Tsuchiya K, Lenoir D et al (2002) Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum Genet 110(2):157–165PubMedCrossRef

57.

Bamford RN, Roessler E, Burdine RD et al (2000) Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 26(3):365–369PubMedCrossRef

58.

Jacquemin E, Cresteil D, Raynaud N, Hadchouel M (2002) CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 34(3):326–327PubMed

59.

Davit-Spraul A, Baussan C, Hermeziu B, Bernard O, Jacquemin E (2008) CFC1 gene involvement in biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 46(1):111–112PubMedCrossRef

60.

Kohsaka T, Yuan ZR, Guo SX et al (2002) The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 36(4 Pt 1):904–912PubMed

61.

Campbell KM, Arya G, Ryckman FC et al (2007) High prevalence of alpha-1-antitrypsin heterozygosity in children with chronic liver disease. J Pediatr Gastroenterol Nutr 44(1):99–103PubMedCrossRef

62.

Hinds R, Davenport M, Mieli-Vergani G, Hadzic N (2004) Antenatal presentation of biliary atresia. J Pediatr 144(1):43–46PubMedCrossRef

63.

Tan CE, Driver M, Howard ER, Moscoso GJ (1994) Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg 29(6):808–814PubMedCrossRef

64.

Hayashida M, Nishimoto Y, Matsuura T et al (2007) The evidence of maternal microchimerism in biliary atresia using fluorescent in situ hybridization. J Pediatr Surg 42:2097–2101PubMedCrossRef

65.

Kobayashi H, Tamatani T, Tamura T et al (2007) Maternal microchimerism in biliary atresia. J Pediatr Surg 42(6):987–991 discussion 991PubMedCrossRef

66.

Klippel CH (1972) A new theory of biliary atresia. J Pediatr Surg 7(6):651–654PubMedCrossRef

67.

Pickett LK, Briggs HC (1969) Biliary obstruction secondary to hepatic vascular ligation in fetal sheep. J Pediatr Surg 4(1):95–101PubMedCrossRef

68.

Ho CW, Shioda K, Shirasaki K, Takahashi S, Tokimatsu S, Maeda K (1993) The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr 16(1):53–60PubMed

69.

Clotman F, Lannoy VJ, Reber M et al (2002) The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 129(8):1819–1828PubMed

70.

Mack CL, Tucker RM, Sokol RJ et al (2004) Biliary atresia is associated with CD4(+) Th1 cell-mediated portal tract inflammation. Pediatr Res 56(1):79–87PubMedCrossRef

71.

Minnick KE, Kreisberg R, Dillon PW (1998) Soluble ICAM-1 (sICAM-1) in biliary atresia and its relationship to disease activity. J Surg Res 76(1):53–56PubMedCrossRef

72.

Leifeld L, Ramakers J, Schneiders AM et al (2001) Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis. J Pathol 194(4):478–483PubMedCrossRef

73.

Landing BH (1974) Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst—the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg 6:113–139PubMed

74.

Domiati-Saad R, Dawson DB, Margraf LR, Finegold MJ, Weinberg AG, Rogers BB (2000) Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr Dev Pathol 3(4):367–373PubMedCrossRef

75.

Fischler B, Ehrnst A, Forsgren M, Orvell C, Nemeth A (1998) The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 27(1):57–64PubMedCrossRef

76.

Drut R, Drut RM, Gomez MA, Cueto Rua E, Lojo MM (1998) Presence of human papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 27(5):530–535PubMedCrossRef

77.

RiepenhoffTalty M, Gouvea V, Evans MJ et al (1996) Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 174(1):8–15

78.

Tyler KL, Sokol RJ, Oberhaus SM et al (1998) Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 27(6):1475–1482PubMedCrossRef

79.

Brown WR, Sokol RJ, Levin MJ et al (1988) Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr 113(4):670–676PubMedCrossRef

80.

Bobo L, Ojeh C, Chiu D, Machado A, Colombani P, Schwarz K (1997) Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res 41(2):229–234PubMedCrossRef

81.

Steele MI, Marshall CM, Lloyd RE, Randolph VE (1995) Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 21(3):697–702PubMed

82.

Tarr PI, Haas JE, Christie DL (1996) Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 97(6 Pt 1):828–831PubMed

83.

Jevon GP, Dimmick JE (1999) Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol 2(1):11–14PubMedCrossRef

84.

Drut R, Gomez MA, Drut RM, Cueto RE, Lojo M (1998) Human papillomavirus, neonatal giant cell hepatitis and biliary duct atresia. Acta Gastroenterol Latinoam 28(1):27–31PubMed

85.

Kahn E (2004) Biliary atresia revisited. Pediatr Dev Pathol 7(2):109–124PubMedCrossRef

86.

Bangaru B, Morecki R, Glaser JH, Gartner LM, Horwitz MS (1980) Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest 43(5):456–462PubMed

87.

Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS (1982) Biliary atresia and reovirus type 3 infection. N Engl J Med 307(8):481–484PubMedCrossRef

88.

Dussaix E, Hadchouel M, Tardieu M, Alagille D (1984) Biliary atresia and reovirus type 3 infection. N Engl J Med 310(10):658PubMed

89.

Glaser JH, Balistreri WF, Morecki R (1984) Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 105(6):912–915PubMedCrossRef

90.

Morecki R, Glaser JH, Johnson AB, Kress Y (1984) Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. Hepatology 4(6):1137–1142PubMedCrossRef

91.

Rosenberg DP, Morecki R, Lollini LO, Glaser J, Cornelius CE (1983) Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta). Hepatology 3(4):577–580PubMedCrossRef

92.

Riepenhofftalty M, Schaekel K, Clark HF et al (1993) Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 33(4):394–399

93.

Petersen C, Biermanns D, Kuske M, Schakel K, MeyerJunghanel L, Mildenberger H (1997) New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg 32(8):1190–1195PubMedCrossRef

94.

Petersen C, Grasshoff S, Luciano L (1998) Diverse morphology of biliary atresia in an animal model. J Hepatol 28(4):603–607PubMedCrossRef

95.

Czech-Schmidt G, Verhagen W, Szavay P, Leonhardt J, Petersen C (2001) Immunological gap in the infectious animal model for biliary atresia. J Surg Res 101(1):62–67PubMedCrossRef

96.

Mack CL, Tucker RM, Sokol RJ, Kotzin BL (2005) Armed CD4(+) Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 115(2):200–209PubMedCrossRef

97.

Mack CL, Tucker RM, Lu BR et al (2006) Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 44(5):1231–1239PubMedCrossRef

98.

Petersen C, Bruns E, Kuske M, VonWussow P (1997) Treatment of extrahepatic biliary atresia with interferon-alpha in a murine infectious model. Pediatr Res 42(5):623–628PubMedCrossRef

99.

Rauschenfels S, Krassmann M, Al-Masri AN et al (2009) Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr 168(4):469–476PubMedCrossRef

100.

Harper P, Plant JW, Unger DB (1990) Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 67(1):18–22PubMedCrossRef

101.

Gosseye S, Otte JB, De Meyer R, Maldague P (1977) A histological study of extrahepatic biliary atresia. Acta Paediatr Belg 30(2):85–90PubMed

102.

Bill AH, Haas JE, Foster GL (1977) Biliary atresia: histopathologic observations and reflections upon its natural history. J Pediatr Surg 12(6):977–982PubMedCrossRef

103.

Ohya T, Fujimoto T, Shimomura H, Miyano T (1995) Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 30(4):515–518PubMedCrossRef

104.

Schreiber RA, Kleinman RE (1993) Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr 16(2):111–113PubMedCrossRef

105.

Urushihara N, Iwagaki H, Yagi T et al (2000) Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 35(3):446–449PubMedCrossRef

106.

Donaldson PT, Manns MP (1999) Immunogenetics of liver disease, 2nd ed. In: Benhamou J-P, McIntyre N, Rizzetto M (eds) Oxford textbook of clinical hepatology. Oxford University Press, Oxford, NY

107.

Silveira TR, Salzano FM, Donaldson PT, Mieli-Vergani G, Howard ER, Mowat AP (1993) Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 16(2):114–117PubMedCrossRef

108.

Broome U, Nemeth A, Hultcrantz R, Scheynius A (1997) Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler’s disease. J Hepatol 26(4):857–862PubMedCrossRef

109.

Donaldson PT, Clare M, Constantini PK et al (2002) HLA and cytokine gene polymorphisms in biliary atresia. Liver 22(3):213–219PubMedCrossRef

110.

A-Kader HH, El-Ayyouti M, Hawas S et al (2002) HLA in Egyptian children with biliary atresia. J Pediatr 141(3):432–434PubMedCrossRef

111.

Bernal W, Moloney M, Underhill J, Donaldson PT (1999) Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 30(2):237–241PubMedCrossRef

112.

Mitchell SA, Grove J, Spurkland A et al (2001) Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 49(2):288–294PubMedCrossRef

113.

Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D (2001) HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48(3):397–402PubMedCrossRef

114.

Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP (2000) Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 46(4):540–545PubMedCrossRef

115.

Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA (2001) Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33(3):708–712PubMedCrossRef

116.

Davenport M, Gonde C, Redkar R et al (2001) Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 36(7):1017–1025PubMedCrossRef

117.

Bezerra JA, Tiao G, Ryckman FC et al (2002) Genetic induction of proinflammatory immunity in children with billary atresia. Lancet 360(9346):1653–1659PubMedCrossRef

118.

Sokol RJ, Mack C, Narkewicz MR, Karrer FM (2003) Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 37(1):4–21PubMedCrossRef

119.

Lu B, Brindley SM, Tucker RM, Lombert C, Mack C (2008) Serum autoantibodies reactive to alpha-enolase and vimentin in murine and human biliary atresia. Hepatology 48(4 Suppl):412A

120.

Lu BR, Mack CL (2009) Inflammation and biliary tract injury. Curr Opin Gastroenterol 25(3):260–264PubMedCrossRef

121.

Funaki N, Sasano H, Shizawa S et al (1998) Apoptosis and cell proliferation in biliary atresia. J Pathol 186(4):429–433PubMedCrossRef

122.

Liu CS, Chiu JH, Chin TW et al (2000) Expression of Fas ligand on bite ductule epithelium in biliary atresia—a poor prognostic factor. J Pediatr Surg 35:1591–1596PubMedCrossRef

123.

Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M (2007) Serial circulating markers of inflammation in biliary atresia—evolution of the post-operative inflammatory process. Hepatology 46(1):180–187PubMedCrossRef

124.

Dillon P, Belchis D, Tracy T, Cilley R, Hafer L, Krummel T (1994) Increased expression of intercellular adhesion molecules in biliary atresia. Am J Pathol 145(2):263–267PubMed

125.

Davenport M, Gonde C, Narayanaswamy B, Mieli-Vergani G, Tredger JM (2005) Soluble adhesion molecule profiling in preoperative infants with biliary atresia. J Pediatr Surg 40(9):1464–1469PubMedCrossRef

Titel: Biliary atresia
verfasst von: Giorgina Mieli-Vergani
Diego Vergani
Publikationsdatum: 01.09.2009
Verlag: Springer-Verlag
Erschienen in: Seminars in Immunopathology / Ausgabe 3/2009
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-009-0171-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

Primary biliary cirrhosis

The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Liver architecture, cell function, and disease

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

Old and rising stars in the lymphoid liver